Radio and PodcastRadio and PodcastLive Radio & Podcasts
Treatment of Complicated Staphylococcus aureus Bacteremia artwork
Science & Medicine

Treatment of Complicated Staphylococcus aureus Bacteremia

JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. by American Medical Association

Aug 13, 202511:35Science & Medicine

Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke Unive...

Related Episodes

Continue listening to more episodes from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians..

Should Everyone be on GLP-1s?

Aug 20, 2026 - 51:54

GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episod...